Stifel Financial Corp increased its position in shares of Agilent Technologies, Inc. (NYSE:A) by 1.2% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 58,796 shares of the medical research company’s stock after purchasing an additional 716 shares during the period. Stifel Financial Corp’s holdings in Agilent Technologies were worth $3,490,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in A. Acrospire Investment Management LLC increased its position in shares of Agilent Technologies by 92.3% during the second quarter. Acrospire Investment Management LLC now owns 2,500 shares of the medical research company’s stock valued at $148,000 after acquiring an additional 1,200 shares during the last quarter. Parallel Advisors LLC increased its position in shares of Agilent Technologies by 5.3% during the second quarter. Parallel Advisors LLC now owns 2,623 shares of the medical research company’s stock valued at $157,000 after acquiring an additional 131 shares during the last quarter. Trust Co. of Vermont increased its position in shares of Agilent Technologies by 1.8% during the second quarter. Trust Co. of Vermont now owns 2,793 shares of the medical research company’s stock valued at $166,000 after acquiring an additional 50 shares during the last quarter. Fiduciary Trust Co. acquired a new stake in shares of Agilent Technologies during the second quarter valued at about $186,000. Finally, Genovese Burford & Brothers Wealth & Retirement Plan Management LLC increased its position in shares of Agilent Technologies by 17.2% during the second quarter. Genovese Burford & Brothers Wealth & Retirement Plan Management LLC now owns 3,319 shares of the medical research company’s stock valued at $196,000 after acquiring an additional 486 shares during the last quarter.

COPYRIGHT VIOLATION WARNING: “Agilent Technologies, Inc. (A) Position Raised by Stifel Financial Corp” was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this article on another website, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The legal version of this article can be accessed at https://www.thecerbatgem.com/2017/10/11/agilent-technologies-inc-a-position-raised-by-stifel-financial-corp.html.

In other Agilent Technologies news, CFO Didier Hirsch sold 1,200 shares of the stock in a transaction that occurred on Wednesday, September 13th. The shares were sold at an average price of $66.00, for a total value of $79,200.00. Following the completion of the sale, the chief financial officer now owns 164,202 shares of the company’s stock, valued at $10,837,332. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Patrick Kaltenbach sold 5,000 shares of the stock in a transaction that occurred on Thursday, July 13th. The shares were sold at an average price of $61.26, for a total transaction of $306,300.00. Following the completion of the sale, the insider now directly owns 45,138 shares of the company’s stock, valued at approximately $2,765,153.88. The disclosure for this sale can be found here. Insiders sold 170,720 shares of company stock valued at $10,795,039 in the last ninety days.

Agilent Technologies, Inc. (NYSE A) opened at 66.60 on Wednesday. The stock has a market cap of $21.43 billion, a P/E ratio of 34.35 and a beta of 1.30. Agilent Technologies, Inc. has a 52 week low of $42.92 and a 52 week high of $66.86. The company has a 50-day moving average of $64.92 and a 200-day moving average of $59.71.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Tuesday, August 15th. The medical research company reported $0.59 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.52 by $0.07. Agilent Technologies had a net margin of 14.36% and a return on equity of 16.95%. The company had revenue of $1.11 billion during the quarter, compared to the consensus estimate of $1.09 billion. During the same quarter last year, the company earned $0.49 earnings per share. Agilent Technologies’s revenue for the quarter was up 6.7% on a year-over-year basis. On average, analysts predict that Agilent Technologies, Inc. will post $2.32 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 25th. Shareholders of record on Tuesday, October 3rd will be given a $0.132 dividend. This represents a $0.53 annualized dividend and a yield of 0.79%. The ex-dividend date is Monday, October 2nd. Agilent Technologies’s dividend payout ratio (DPR) is 27.32%.

A number of equities research analysts have weighed in on A shares. BidaskClub cut shares of Agilent Technologies from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, June 13th. Deutsche Bank AG reiterated a “buy” rating and set a $66.00 price target on shares of Agilent Technologies in a research report on Thursday, June 22nd. Morgan Stanley reiterated an “overweight” rating on shares of Agilent Technologies in a research report on Monday, July 10th. Wells Fargo & Company upgraded shares of Agilent Technologies from a “market perform” rating to an “outperform” rating and lifted their price target for the company from $42.92 to $60.73 in a research report on Wednesday, July 12th. Finally, Barclays PLC reiterated a “buy” rating and set a $67.00 price target on shares of Agilent Technologies in a research report on Wednesday, July 19th. Four analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. Agilent Technologies currently has an average rating of “Buy” and an average price target of $65.12.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Stock Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related stocks with our FREE daily email newsletter.